ACQUISITION–RELATED CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables)

3 Months Ended

Mar. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Acquisition-related Restructuring and Discontinuation Costs

Acquisition-related charges, product discontinuation and other for the three months ended March 31, 2022 and 2021 summarized below (in thousands):

	Three Months Ended March 31,
	2022		2021
Severance-related expenses	$	3,115	$	—
Acquisition-related fees	1,845		—
Other acquisition expenses	448		—
Total acquisition-related charges	5,408		—
Flexion contingent consideration	(794)		—
MyoScience contingent consideration	(277)		(1,127)
Nuance Biotech Co. Ltd. agreement dissolution costs	—		3,000
Total acquisition-related charges, product discontinuation and other	$	4,337	$	1,873